Asa Gold & Precious Metals LTD Has Cut By $1.50 Million Its Barrick Gold (ABX) Stake; Shorts at SANUWAVE HEALTH (SNWV) Lowered By 79.26%

June 7, 2017 - By Vivian Currie

Asa Gold & Precious Metals Ltd decreased Barrick Gold Corp (ABX) stake by 7.84% reported in 2016Q4 SEC filing. Asa Gold & Precious Metals Ltd sold 100,000 shares as Barrick Gold Corp (ABX)’s stock declined 17.45%. The Asa Gold & Precious Metals Ltd holds 1.18M shares with $18.78 million value, down from 1.28 million last quarter. Barrick Gold Corp now has $19.84B valuation. The stock declined 0.76% or $0.13 reaching $16.91 per share. About 52,443 shares traded. Barrick Gold Corp (USA) (NYSE:ABX) has declined 8.26% since June 7, 2016 and is downtrending. It has underperformed by 24.96% the S&P500.

SANUWAVE HEALTH INCORPORATED (OTCMKTS:SNWV) had a decrease of 79.26% in short interest. SNWV’s SI was 3,900 shares in June as released by FINRA. Its down 79.26% from 18,800 shares previously. The stock increased 10.27% or $0.009 on June 6, reaching $0.102. About 43,879 shares traded. SANUWAVE Health, Inc. (OTCMKTS:SNWV) has 0.00% since June 7, 2016 and is . It has underperformed by 16.70% the S&P500.

SANUWAVE Health, Inc. is an acoustic pressure shock wave technology firm using a system of noninvasive, high-energy, acoustic pressure shock waves for indications, such as regenerative medicine and other applications. The company has market cap of $14.18 million. The Firm is focused on regenerative medicine utilizing noninvasive , acoustic pressure shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue and vascular structures. It currently has negative earnings. The Company’s lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers.

Analysts await Barrick Gold Corp (USA) (NYSE:ABX) to report earnings on July, 26. They expect $0.24 EPS, up 71.43% or $0.10 from last year’s $0.14 per share. ABX’s profit will be $281.58 million for 17.61 P/E if the $0.24 EPS becomes a reality. After $0.14 actual EPS reported by Barrick Gold Corp (USA) for the previous quarter, Wall Street now forecasts 71.43% EPS growth.

Among 22 analysts covering Barrick Gold Corp. (NYSE:ABX), 11 have Buy rating, 1 Sell and 10 Hold. Therefore 50% are positive. Barrick Gold Corp. had 56 analyst reports since August 6, 2015 according to SRatingsIntel. Mackie downgraded the stock to “Sell” rating in Monday, June 20 report. The rating was initiated by Citigroup with “Buy” on Tuesday, August 2. Barclays Capital downgraded it to “Equal Weight” rating and $10 target in Friday, August 7 report. Canaccord Genuity downgraded Barrick Gold Corp (USA) (NYSE:ABX) on Tuesday, May 3 to “Hold” rating. The stock has “Neutral” rating by Macquarie Research on Wednesday, August 19. The rating was maintained by RBC Capital Markets with “Sector Perform” on Friday, September 18. Clarkson Capital initiated the shares of ABX in report on Tuesday, February 16 with “Neutral” rating. HSBC maintained the shares of ABX in report on Tuesday, September 8 with “Buy” rating. The firm has “Neutral” rating given on Tuesday, March 15 by JP Morgan. The stock of Barrick Gold Corp (USA) (NYSE:ABX) has “Buy” rating given on Friday, April 7 by Jefferies.